In the news
Scenario Analysis When Conducting Budget Impact Analyses for Rare Diseases
October 5, 2022AJMC
Related news
In the news
April 13, 2023
Prime, Magellan Studies Reveal Ways to Squeeze More Value From Specialty Drugs
AIS Health – Radar on Specialty Pharmacy
In the news
March 29, 2023
Adeno-Associated Virus Gene Therapies in the Pipeline, Barriers to Existing Drugs and Solutions | AMCP 2023
Managed Healthcare Executive
In the news
March 29, 2023
Magellan Team Discusses ‘Mortgage-like’ Payments For Ultra-Expensive Gene Therapies | AMCP 2023
Managed Healthcare Executive